Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 3764,26 zł, with a 24-hour trading volume of 14,5B zł. The asset's market cap is 3,36T zł, after moving 0.53% in the last day.
Tokenized Eli Lilly And Co is trading at 3766,2 zł, with a tokenized market cap of 20,71M zł and a 24-hour trading volume of 4,59M zł. The tokenized asset has moved -1.03% in the past 24 hours.